A carregar...

An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia

SIMPLE SUMMARY: B cell acute lymphoblastic leukemia (B-ALL) is a common blood cancer characterized by proliferating and accumulating malignant, immature B cells within the body. Despite recent successes in B-ALL therapy, there is still a need for new therapeutic options. In the present study, we rep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Riegg, Fabian, Lutz, Martina S., Schmied, Bastian J., Heitmann, Jonas S., Queudeville, Manon, Lang, Peter, Jung, Gundram, Salih, Helmut R., Märklin, Melanie
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036612/
https://ncbi.nlm.nih.gov/pubmed/33915811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071632
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!